The study design illustrated here shows the treatment phase with combination paclitaxel and pembrolizumab, followed by maintenance pembrolizumab if disease is stable or improved after 6 months of combination therapy.
No takes yet. Share an insight, caveat, or question.
Bitting et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: